Insider Sell: Timothy Mahoney Sells Shares of Agrify Corp (AGFY)

Author's Avatar
3 days ago
Article's Main Image

On June 26, 2025, Timothy Mahoney, a Director at Agrify Corp (AGFY, Financial), sold 4,999 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 5,000 shares of the company. Agrify Corp is a company that provides advanced cultivation and extraction solutions for the cannabis and hemp industry. The company offers a range of products and services designed to optimize the growth and processing of cannabis and hemp plants. 1939808848651120640.png Over the past year, Timothy Mahoney has sold a total of 13,329 shares and has not purchased any shares. The insider transaction history for Agrify Corp shows that there have been 2 insider buys and 10 insider sells over the same timeframe. 1939808884021686272.png On the day of the recent sale, shares of Agrify Corp were trading at $20.29 each, giving the stock a market cap of $41.334 million. With a price of $20.29 and a GF Value of $0.32, Agrify Corp has a price-to-GF-Value ratio of 63.41, indicating that the stock is significantly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at. It also includes a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.